Breathe Hope Research Group Launches Lung Cancer and Anxiety Survey

The following is a letter from the Breathe Hope Research Group Dear Canadian Lung Cancer Patients, A group of lung cancer patients is conducting this survey with a common interest in research on lung cancer. Anxiety, fear and worry are common concerns among lung cancer patients. While mental health has been studied amongst cancer patients in general, there is little information about lung cancer. We

As Biosimilars Expand in Ontario, Patient Self-Advocacy is Key

In the last days of 2022, the Government of Ontario decided to put its weight behind the use of biosimilars. Starting March 31st, 2023, Ontario Drug Benefit recipients who are using an originator biologic will be transferred to a biosimilar at no cost. Drugs like Copaxone®, Enbrel®, Humalog®, Humira®, Lantus®, NovoRapid®, Remicade®, and Rituxan® are to be phased out, with patients required to transition by